Technology | Radiation Therapy | October 18, 2016

Elekta Introduces Leksell Vantage Stereotactic System for Neurosurgery

Novel head frame designed for greater patient comfort and improved clinical workflow

October 18, 2016 — Elekta introduced the Leksell Vantage Stereotactic System, its latest system for very precise neurosurgery, at the European Society for Stereotactic and Functional Neurosurgery (ESSFN) meeting, Sept. 28 – Oct. 1, in Madrid.

Based on the Leksell Stereotactic System, Leksell Vantage addresses the limitations of using metal components during stereotactic magnetic resonance (MR) and computed tomography (CT) imaging. Constructed of a novel epoxy composite, the robust, metal-free head frame design may allow for faster and better stereotactic imaging. This means higher resolution MR imaging of the brain and fewer artifacts introduced in stereotactic CT scanning.

Also important to clinicians is the new stereotactic arc, a surgical positioning device that enables a faster preparation of the sterile field. Target coordinates are easily set between the left and the right brain hemisphere in deep brain stimulation (DBS) lead placements.

Leksell Vantage’s lightweight, open face design is created to improve the patient experience. In addition to making it easier to eat or drink while the frame is on, it has the potential to reduce MR scanning times. It essentially eliminates the risk of device-related skin sensations due to temperature increase during MR scans.

Stereotactic neurosurgery is a specialty often used for DBS implantations, brain biopsies and drug deliveries to delicate brain targets, as well as cranial radiosurgery.

Leksell Vantage Stereotactic System is not yet CE marked or U.S. Food and Drug Administration (FDA) 510(k) cleared and is not available for sale or distribution. It is expected to be available for clinical use in Europe during 2017.

The Leksell Vantage head frame is designed to be compatible with Leksell Gamma Knife Icon in a future release.

For more information: www.elekta.com

Related Content

Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof
Southern Asia's First Proton Therapy Center Begins Treatments
News | Proton Therapy | January 28, 2019
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the...
Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus